Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01SHR
|
|||
Former ID |
DNC008661
|
|||
Drug Name |
((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine
|
|||
Synonyms |
CHEMBL498509; ((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine; SCHEMBL5808356; BDBM50272715
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H19NO2
|
|||
Canonical SMILES |
CC1=CC=CC=C1OC2C(COC3=CC=CC=C23)CN
|
|||
InChI |
1S/C17H19NO2/c1-12-6-2-4-8-15(12)20-17-13(10-18)11-19-16-9-5-3-7-14(16)17/h2-9,13,17H,10-11,18H2,1H3/t13-,17-/m1/s1
|
|||
InChIKey |
RQRGTZIPGLRQOJ-CXAGYDPISA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Norepinephrine transporter (NET) | Target Info | Inhibitor | [1] |
Serotonin transporter (SERT) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
5HT1 type receptor mediated signaling pathway | ||||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
SIDS Susceptibility Pathways | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4495-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.